NRP1 and cancer: In addition to the discovery of NRP1 as a SARS-CoV-2 entry coreceptor along with ACE2, we have assembled the pathological roles of NRPs and their involvement in clinical diseases, particularly highlighting the participation of NRPs in cancer.